← REGULATORY CHANGES
FEDERAL REGISTER · RULENovember 9, 2023IN FORCE

Medical Devices; Hematology and Pathology Devices; Classification of the Container System for the Processing and Storage of Red Blood Cell Components Under Reduced Oxygen Conditions

What this record is not

Document details are published in the U.S. Federal Register; SPEQ surfaces them for reference and is not affiliated with or endorsed by the FDA or the Office of the Federal Register. The authoritative text is on federalregister.gov.

STATUSIN FORCE
EFFECTIVENov 9, 2023
COMMENTS CLOSE—
APPLIES TO · SPEQ TAGBiologicsDevice
Document type
Rule
Agency
Health and Human Services Department
Published
November 9, 2023
Effective
November 9, 2023
Document number
2023-24717
CFR references
21 CFR 864
Docket
FDA-2023-N-4487
ABSTRACT

The Food and Drug Administration (FDA, Agency, or we) is classifying the container system for the processing and storage of Red Blood Cell components under reduced oxygen conditions into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for the classification of the container system for the processing and storage of Red Blood Cell components under reduced oxygen conditions. We are taking this action because we have determined that classifying the device into class II (special controls) will provide a reasonable assurance of safety and effectiveness of the device. We believe this action will also enhance patients' access to beneficial innovative devices.

Abstract as published in the Federal Register.